Dr. Sorah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, NC 27514
Education & Training
- University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2020 - 2023
- University of North Carolina HospitalsResidency, Internal Medicine, 2017 - 2020
- Virginia Commonwealth University School of MedicineClass of 2017
- Virginia TechBS in Biochemistry, BA in Spanish, Summa Cum Laude, 2008 - 2012
Certifications & Licensure
- NC State Medical License 2017 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 18 citationsIncidence and Prediction of Immune Checkpoint Inhibitor-related Nephrotoxicity.Jonathan D Sorah, Tracy L. Rose, Roshni Radhakrishna, Vimal K. Derebail, Matthew I. Milowsky
Journal of Immunotherapy. 2021-04-01 - 5 citationsPhase II Single-Arm Study of Palbociclib and Cetuximab Rechallenge in Patients with KRAS/NRAS/BRAF Wild-Type Colorectal Cancer.Jonathan D Sorah, Dominic T Moore, Matthew J Reilley, Mohamed E Salem, Tammy Triglianos
The Oncologist. 2022-12-09 - A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer.Hanna K Sanoff, Allison M Deal, Jai Patel, Jonathan D Sorah, Jacquelyne Gaddy
The Oncologist. 2024-09-06
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: